Gurjyot K. Doshi, MD

Articles by Gurjyot K. Doshi, MD

Updated ASCO-NCODA MIP Standards Emphasize Health Equity, Patient-Centered Care, and Integrated Workflows in Oral Oncolytic Management

ByGurjyot K. Doshi, MD,Aislinn Antrim, Managing Editor

May 31st 2025

Gurjyot K. Doshi, MD, discusses key updates to medically integrated pharmacy standards, which reflect the evolving landscape of oral oncolytic therapy.

Latest Updated Articles

Updated ASCO-NCODA MIP Standards Emphasize Health Equity, Patient-Centered Care, and Integrated Workflows in Oral Oncolytic Management
Published: May 31st 2025 | Updated:

Gurjyot K. Doshi, MD

Articles by Gurjyot K. Doshi, MD

Updated ASCO-NCODA MIP Standards Emphasize Health Equity, Patient-Centered Care, and Integrated Workflows in Oral Oncolytic Management

Latest Updated Articles

Trending on Pharmacy Times

Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2

Current and Emerging BCMAxCD3 Bispecifics

Same Pathway, Different Profiles: Clinical Considerations for Alpelisib, Capivasertib, and Inavolisib

Evolocumab Reduces Risk of Major Events in Patients Without Prior Cardiovascular History

Biosimilar Stivant Shows Noninferior Efficacy and Comparable Safety to Reference Bevacizumab